drugset / Trial / NCT02072174

Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children

NCT02072174 ↗

Phase 4 Completed 569 enrolled Materia Medica Holding
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is: • To obtain additional data on therapeutic efficacy of Anaferon for children in the treatment of influenza and acute respiratory viral infections in children

Timeline

Start
2014-10-08
Primary completion
2018-04-16
Completion
2018-04-16

Outcome

Met primary endpoint

registry analysis (superiority test); Anaferon for Children vs Placebo; p = 0.0242; Kruskal-Wallis NCT02072174 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Anaferon for Children Unknown — Oral